Derk C.F. Klatte

519 total citations
23 papers, 303 citations indexed

About

Derk C.F. Klatte is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Derk C.F. Klatte has authored 23 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Derk C.F. Klatte's work include Pancreatic and Hepatic Oncology Research (14 papers), Cancer Genomics and Diagnostics (8 papers) and BRCA gene mutations in cancer (3 papers). Derk C.F. Klatte is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Cancer Genomics and Diagnostics (8 papers) and BRCA gene mutations in cancer (3 papers). Derk C.F. Klatte collaborates with scholars based in Netherlands, United States and United Arab Emirates. Derk C.F. Klatte's co-authors include Monique E. van Leerdam, Friedo W. Dekker, Michael B. Wallace, Juan Jesús Carrero, Josef Coresh, Anna L.V. Johansson, Jeanin E. van Hooft, Marco J. Bruno, Marco Trevisan and Morgan E. Grams and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Derk C.F. Klatte

18 papers receiving 296 citations

Peers

Countries citing papers authored by Derk C.F. Klatte

Since Specialization

Citations

This map shows the geographic impact of Derk C.F. Klatte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derk C.F. Klatte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derk C.F. Klatte more than expected).

Fields of papers citing papers by Derk C.F. Klatte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derk C.F. Klatte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derk C.F. Klatte. The network helps show where Derk C.F. Klatte may publish in the future.

Co-authorship network of co-authors of Derk C.F. Klatte

This figure shows the co-authorship network connecting the top 25 collaborators of Derk C.F. Klatte. A scholar is included among the top collaborators of Derk C.F. Klatte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derk C.F. Klatte. Derk C.F. Klatte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals 2025 ·Best Practice & Research Clinical Gastroenterology ·(unknown), Pilar Acedo, Michael B. Wallace, Monique E. van Leerdam, Derk C.F. Klatte	0
2	Psychological Distress and Quality of Life in Families With a Germline CDKN2A Pathogenic Variant 2025 ·Molecular Genetics & Genomic Medicine ·(unknown), Derk C.F. Klatte, Jeanin E. van Hooft, (unknown), (unknown), Remco van Doorn, Chris Hinnen, Thomas P. Potjer, Eveline M. A. Bleiker, Monique E. van Leerdam	0
3	Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer 2024 ·Familial Cancer ·(unknown), Jeanin E. van Hooft, Bas Boekestijn, Bert A. Bonsing, Martin N.J.M. Wasser, Derk C.F. Klatte, Monique E. van Leerdam	5
4	Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma 2024 ·JCO Oncology Practice ·Derk C.F. Klatte, Jason S. Starr, (unknown), (unknown), Jeanin E. van Hooft, Monique E. van Leerdam, Thomas P. Potjer, (unknown), Douglas L. Riegert‐Johnson, Michael B. Wallace, Yan Bi	7
5	The Added Value of Blood Glucose Monitoring in High-Risk Individuals Undergoing Pancreatic Cancer Surveillance 2024 ·Pancreas ·(unknown), (unknown), Akin Inderson, Bas Boekestijn, Bert A. Bonsing, Hans F. A. Vasen, Jeanin E. van Hooft, Jurjen J. Boonstra, J. Sven D. Mieog, Martin N.J.M. Wasser, Shirin Feshtali, Thomas P. Potjer, Derk C.F. Klatte, Monique E. van Leerdam	1
6	Attitudes toward genetic testing, family planning and preimplantation genetic testing in families with a germline CDKN2A pathogenic variant 2024 ·Familial Cancer ·(unknown), Derk C.F. Klatte, Jeanin E. van Hooft, (unknown), (unknown), Remco van Doorn, (unknown), Thomas P. Potjer, Eveline M. A. Bleiker, Monique E. van Leerdam	2
7	Temporal Trends in Body Composition and Metabolic Markers Prior to Diagnosis of Pancreatic Ductal Adenocarcinoma 2024 ·Clinical Gastroenterology and Hepatology ·Derk C.F. Klatte, Alexander D. Weston, (unknown), (unknown), (unknown), Candice W. Bolan, Megan Engels, Jeanin E. van Hooft, Monique E. van Leerdam, (unknown), Michael B. Wallace, (unknown)	8
8	Pancreatic cancer surveillance: Risk stratification of individuals with a germline CDKN2A pathogenic variant 2024 ·United European Gastroenterology Journal ·Derk C.F. Klatte, (unknown), Djuna L. Cahen, Merel van Diepen, Marco J. Bruno, Monique E. van Leerdam, (unknown)	2
9	Psychosocial issues of individuals undergoing surveillance for increased risk of melanoma and pancreatic cancer due to a germline CDKN2A variant: A focus group study 2023 ·Journal of Genetic Counseling ·Derk C.F. Klatte, (unknown), Chris Hinnen, Remco van Doorn, Thomas P. Potjer, Monique E. van Leerdam, Eveline M. A. Bleiker	4
10	Tu1986 A FULLY AUTOMATIC AI SYSTEM FOR PANCREAS SEGMENTATION FROM MULTICENTER MRI SCANS 2023 ·Gastroenterology ·Zheyuan Zhang, Ulaş Bağcı, Elif Keleş, Camila Lopes Vendrami, Sachin Jambawalikar, Derk C.F. Klatte, Megan Engels, Candice W. Bolan, Emil Agarunov, Tamas A. Gonda, Rajesh N. Keswani, Frank H. Miller, Cemal Yazıcı, Michael B. Wallace, Ivo G. Schoots, Marco J. Bruno, Temel Tirkes	0
11	Identification of individuals at high-risk for pancreatic cancer using a digital patient-input tool combining family cancer history screening and new-onset diabetes 2023 ·Preventive Medicine Reports ·Derk C.F. Klatte, (unknown), (unknown), (unknown), (unknown), (unknown), Michael B. Wallace	0
12	Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance 2023 ·British journal of surgery ·(unknown), (unknown), Derk C.F. Klatte, (unknown), J. Sven D. Mieog, Alexander L. Vahrmeijer, Jeanin E. van Hooft, Monique E. van Leerdam, Bert A. Bonsing	2
13	Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis 2023 ·Gastroenterology ·Derk C.F. Klatte, Bas Boekestijn, (unknown), Friedo W. Dekker, Lydia G. van der Geest, Martin N.J.M. Wasser, Shirin Feshtali, J. Sven D. Mieog, Saskia Luelmo, Hans Morreau, Thomas P. Potjer, Akin Inderson, Jurjen J. Boonstra, Hans F. A. Vasen, Jeanin E. van Hooft, Bert A. Bonsing, Monique E. van Leerdam	35
14	Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals 2022 ·Pancreatology ·Iris J. M. Levink, Derk C.F. Klatte, (unknown), Gerda C. M. Vreeker, Isaura S. Ibrahim, Yuri E. M. van der Burgt, Kasper A. Overbeek, Brechtje D.M. Koopmann, Djuna L. Cahen, Gwenny M. Fuhler, Manfred Wuhrer, Bert A. Bonsing, Rob A.�E.�M. Tollenaar, Frank P. Vleggaar, Hans F. A. Vasen, Monique E. van Leerdam, Marco J. Bruno, Wilma E. Mesker	10
15	Hereditary pancreatic cancer 2022 ·Best Practice & Research Clinical Gastroenterology ·Derk C.F. Klatte, Michael B. Wallace, Matthias Löhr, Marco J. Bruno, Monique E. van Leerdam	38
16	Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up 2022 ·Journal of Clinical Oncology ·Derk C.F. Klatte, Bas Boekestijn, Martin N.J.M. Wasser, (unknown), Isaura S. Ibrahim, J. Sven D. Mieog, Saskia Luelmo, Hans Morreau, Thomas P. Potjer, Akin Inderson, Jurjen J. Boonstra, Friedo W. Dekker, Hans F. A. Vasen, Jeanin E. van Hooft, Bert A. Bonsing, Monique E. van Leerdam	60
17	Health outcomes and experiences of direct-to-consumer high-intensity screening using both whole-body magnetic resonance imaging and cardiological examination 2020 ·PLoS ONE ·Daniël W. Hommes, Derk C.F. Klatte, Wilma Otten, (unknown), (unknown), (unknown), (unknown)	3
18	Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease 2017 ·Gastroenterology ·Derk C.F. Klatte, Alessandro Gasparini, Hong Xu, (unknown), Marco Trevisan, Anna L.V. Johansson, Björn Wettermark, Johan Ärnlöv, Cynthia Janmaat, Bengt Lindholm, Friedo W. Dekker, Josef Coresh, Morgan E. Grams, Juan Jesús Carrero	116
19	Inverted Y-Ureteral Duplication with an Uterine Ectopy as Cause of Ureteric Enuresis 1989 ·Urologia Internationalis ·(unknown), Derk C.F. Klatte	6
20	[Intracavitary methylene blue dye in the diagnosis of dysplasias and tumors of the urinary bladder]. 1987 ·PubMed ·(unknown), Derk C.F. Klatte, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact